Evidence map›Paper›PMID 29867499›Full record

ArticleFrontiers in pharmacology2018

The Natural Flavone Acacetin Confers Cardiomyocyte Protection Against Hypoxia/Reoxygenation Injury via AMPK-Mediated Activation of Nrf2 Signaling Pathway.

Wei-Yin Wu, Yun-Da Li, Yu-Kai Cui, Chan Wu, Yi-Xiang Hong, Gang Li, Yao Wu, Ling-Jun Jie, Yan Wang, Gui-Rong Li

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 78 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Metabolites Analysis of Anti-Myocardial Ischemia Active Components ofInternational journal of molecular sciences · 2022
    Article
  17. Article
  18. Review
  19. Article
  20. Acacetin as a Potential Protective Compound against Cardiovascular Diseases.Evidence-based complementary and alternative medicine : eCAM · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Wei-Yin WuXiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
Yun-Da LiXiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
Yu-Kai CuiXiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
Chan WuXiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
Yi-Xiang HongXiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
Gang LiXiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
Yao WuXiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
Ling-Jun JieXiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
Yan WangXiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
Gui-Rong LiXiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
First Affiliated Hospital of Xiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study investigates the potential signal pathway of acacetin in cardioprotection against ischemia/reperfusion injury using an

Indexed as

acacetinAMPKcardioprotectionhypoxia-reoxygenationNrf2

Identifiers

PMID29867499
PMCPMC5962741
OpenAlexW2799935319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.